Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.35 |
| ▸ | FAAH | O00519 | 8/20 | 0.32 |
| ▸ | CES1 | P23141 | 5/20 | 0.31 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29368701 | 0.85 | FAAH (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29367428 | 0.84 | CHRM2 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29365529 | 0.82 | CHRM2 (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29368734 | 0.81 | FAAH (0.39) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9108572 | 0.81 | FAAH (0.32) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17926685 | 0.77 | CHRM2 (0.31) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29367409 | 0.76 | FAAH (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL23035533 | 0.75 | CHRM2 (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL11270523 | 0.75 | CHRM2 (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL231141 | 0.75 | CHRM2 (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111886676-B | Method for treating surface of wafer and composition therefor | 中央硝子株式会社 | 2024-09-27 | — | — | CN | claimed |
| US-12416028-B2 | Biosynthetic production of gamma- and delta-lactones using cytochrome P450 enzymes having subterminal hydroxylase activity | CONAGEN INC. (US) | 2025-09-16 | — | — | US | disclosed |
| CN-111742391-B | Chemical solution for forming water-repellent protective film, method for producing same, and method for producing surface-treated body | 中央硝子株式会社 | 2025-02-18 | — | — | CN | disclosed |
| US-12098319-B2 | Liquid chemical for forming water-repellent protective film, method for preparing same, and method for manufacturing surface-treated body | CENTRAL GLASS COMPANY, LIMITED (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-113557259-B | Biosynthesis of gamma-and delta-lactones using cytochrome P450 enzymes with subterminal hydroxylase activity | 科纳根公司 | 2024-03-08 | — | — | CN | disclosed |
| US-20230387464-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| US-20230387464-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| US-11670498-B2 | Surface treatment agent and surface-treated body manufacturing method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2023-06-06 | — | — | US | disclosed |
| US-20230125746-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230125746-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-1165552-A1 | C7 CARBONATE SUBSTITUTED TAXANES AS ANTITUMOR AGENTS | Florida State University Research Foundation, Inc. (US) | 2002-01-02 | — | — | EP | disclosed |
| EP-0956284-A4 | PROCESS FOR SELECTIVE DERIVATIZATION OF TAXANES | UNIV FLORIDA STATE (US) | 2001-12-05 | — | — | EP | disclosed |
| US-6291691-B1 | CONVERTING THE C(7) HYDROXY GROUP OF A 10-ACYLOXY-9-OXO-7-HYDROXYTAXANE TO AN ACETAL OR KETAL, BY REACTING WITH KETALIZING AGENT IN PRESENCE OF AN ACID CATALYST TO FORM | FLORIDA STATE UNIVERSITY | 2001-09-18 | — | — | US | disclosed |
| WO-2001057027-A1 | C7 ESTER SUBSTITUTED TAXANES AS ANTITUMOR AGENTS | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2001-08-09 | — | — | WO | disclosed |
| WO-2001057030-A1 | C7 CARBONATE SUBSTITUTED TAXANES AS ANTITUMOR AGENTS | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2001-08-09 | — | — | WO | disclosed |
| US-6191287-B1 | TREATING THE TAXANE WITH A SILYAMIDE OR A BISSILYLAMIDE TO FORM C10 SILYLATED TAXANE | FLORIDA STATE UNIVERSITY | 2001-02-20 | — | — | US | disclosed |
| CN-1239476-A | Process for selective derivatization of taxanes | UNIV FLORIDA STATE (US) | 1999-12-22 | — | — | CN | disclosed |
| EP-0956284-A1 | PROCESS FOR SELECTIVE DERIVATIZATION OF TAXANES | Florida State University (US) | 1999-11-17 | — | — | EP | disclosed |
| WO-1999009021-A1 | PROCESS FOR SELECTIVE DERIVATIZATION OF TAXANES | FLORIDA STATE UNIVERSITY (US) | 1999-02-25 | — | — | WO | disclosed |
| EP-0589914-A1 | NOVEL 3-FUSED PYRIDINIUMMETHYL CEPHALOSPORINS | CHEIL FOODS & CHEMICALS, INC. (KR) | 1994-04-06 | — | — | EP | disclosed |